查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829248

2025年全球智慧胰岛素笔市场报告

Smart Insulin Pens Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，智慧胰岛素笔市场规模强劲成长，从2024年的1.1亿美元成长到2025年的1.1亿美元，复合年增长率为6.1%。这段时期的成长归因于糖尿病盛行率的上升、新兴市场的强劲经济年复合成长率、老年人口的成长、医疗支出的增加以及公共医疗保险改革。

智慧胰岛素笔市场规模预计在未来几年强劲成长，到2029年将达到1.5亿美元，复合年增长率为7.0%。预测期内的增长可归因于疾病负担的增加、政府措施以及技术进步。预测期内的主要趋势包括与科技公司的合作、智慧胰岛素给药设备、新型胰岛素给药方式、物联网整合以及併购的增加。

智慧胰岛素笔是指一种用于监测和记录给药资讯（如剂量、时间、类型等）的胰岛素传输装置。此外，这些设备还可以提供报告等功能，以便与医疗保健专业人员共用。

智慧胰岛素笔有两种类型：第一代和第二代（配备蓝牙或USB连接）。第二代智慧型胰岛素笔配备蓝牙或USB连接功能，方便更密切的监测。这些笔有预填充和可重复使用两种版本，可用于治疗第1型和第2型糖尿病。智慧胰岛素笔的终端使用者多种多样，包括医院、诊所、门诊手术中心和居家医疗机构。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供智慧胰岛素笔市场统计数据，包括全球智慧胰岛素笔市场规模、各地区市场份额、竞争对手的市场份额、智慧胰岛素笔市场细分、市场趋势和商机，以及在智慧胰岛素笔行业取得成功所需的数据。本智慧胰岛素笔市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

未来五年7.0%的预测成长率，较我们先前对该市场的预测略有下降0.5%。下降的主要原因是美国与其他国家之间关税的影响。这种影响将直接影响美国，导致剂量追踪微处理器和精密注射器的供应链中断，以及来自爱尔兰和以色列的关键进口产品，可能会推迟糖尿病管理解决方案的推出。此外，互惠关税以及贸易紧张局势和限制升级对全球经济和贸易的负面影响也将对美国产生更广泛的影响。

与胰岛素管瓶或註射器相比，使用胰岛素笔更容易达到精准的胰岛素给药。例如，对于需要在学校上课期间注射胰岛素的儿童或视力受损的糖尿病患者，胰岛素笔可以透过剂量刻度盘预设精确剂量，确保注射时剂量准确。儿童胰岛素笔，例如诺和诺德的 Echo Plus，允许最多 30 个单位的半剂量给药。此外，礼来的 HumaPen LaXura HD 允许半剂量给药，而诺和诺德的 NovoPen Junior 即使在半剂量下也能进行微调，从而实现精准的胰岛素给药。智慧胰岛素笔提供的剂量调整和给药准确性可以防止剂量过量和剂量不足，从而推动智慧胰岛素笔需求的预期成长，并推动市场成长。

预计全球糖尿病人口的成长将在未来几年显着推动智慧胰岛素笔市场的成长。糖尿病人口包括被诊断患有糖尿病的人，糖尿病是一种以血糖值升高为特征的慢性疾病。智慧胰岛素笔透过提供准确的胰岛素剂量追踪、提醒和数据整合来增强糖尿病管理，提高糖尿病患者的治疗依从性和整体血糖控制。例如，2022 年 7 月，总部位于比利时的非营利组织国际糖尿病联盟报告称，2022 年全球约有 5.37 亿成年人将患糖尿病。预计到 2030 年这一数字将增至 6.43 亿，到 2045 年将增至 7.83 亿。因此，全球糖尿病人口的成长正在推动智慧胰岛素笔市场的成长。

下一代智慧胰岛素笔超越了简单的记忆体存储，能够协助进行个人化剂量计算、持续追踪血糖浓度，并连接到智慧型手机应用程式进行数据视觉化。 2022年4月，美国跨国製药公司礼来公司推出了Tempo®个人化糖尿病管理平台。此综合系统旨在改善第1型和第2型糖尿病成年人的糖尿病自我管理。 Tempo智慧按钮是一种可重复使用的设备，可连接到Tempo笔上以捕获和传输胰岛素剂量数据，而TempoSmart™应用程式则记录这些剂量数据并提供个人化教育和用药提醒。

为了优化市场收益，智慧胰岛素笔市场的主要企业正策略性地专注于推出易于使用的胰岛素笔，例如 NovoPen 6 和 NovoPen Echo Plus。这些自行注射笔会在每次注射后自动记录胰岛素注射资讯。例如，2022 年 3 月，丹麦製药公司 Novo Nordisk A/S 推出了首款智慧胰岛素笔—NovoPen 6 和 NovoPen Echo Plus。这些笔记录胰岛素注射的时间和剂量等详细信息，并透过近距离场通讯(NFC) 将数据上传到应用程式。这些笔有助于传输到患者首选的糖尿病应用程序，从而实现与医疗保健提供者的数据共用。它们与智慧型手机、平板电脑、个人电脑、血糖值监测仪和其他支援 NFC 的装置相容。

2023年10月，诺和诺德以1.645亿美元收购了法国医疗设备公司Biocorp，该公司专门从事药物输送系统和医疗设备的开发和製造。此次收购预计将使诺和诺德能够进一步投资Biocorp的设备开发，并加速公司在设备和输送解决方案方面的雄心壮志。

智慧胰岛素笔市场的主要企业包括 Companion Medical、Novo Nordisk A/S、F. Hoffmann-La Roche AG、Emperra GmbH E-Health Technologies、Diamesco Co.Ltd.、Digital Medics Pvt Ltd.、Bigfoot Biomedical、Diabnext、Insulet Corporation、江苏德福医疗有限公司、Sanoon.Iconn. Johnson、COVIDien Healthcare、Philips Healthcare India、山东威高集团医用聚合物有限公司、Yuwell medical equipment & supply Co.、Terumo、NIPRO、Olympus Medical Systems、Nihon Koden、Medtronic PLC、Ypsomed Holding AG、Berlin-Chemie AG、Patabors Penetand、Delk、Getand Lt. Diabetes Care, Inc.

2024年，智慧胰岛素笔市场最大的地区是北美。就全球智慧型胰岛素笔市占率而言，西欧是第二大地区。智慧胰岛素笔市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

智慧胰岛素笔市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、加拿大和西班牙。

智慧胰岛素笔市场涵盖第一代和第二代（支援蓝牙和USB连接）等设备的销售。该市场的价值指的是出厂价，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球智慧型胰岛素笔：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球智慧型胰岛素笔市场：成长率分析
  • 全球智慧胰岛素笔市场表现：规模与成长，2019-2024
  • 全球智慧胰岛素笔市场预测：规模与成长，2024-2029年，2034年
  • 全球智慧胰岛素笔：总目标市场（TAM）

第六章 市场细分

  • 全球智慧型胰岛素笔市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 第一代笔
  • 第二代笔
  • 全球智慧胰岛素笔市场：按使用者性别、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 预填充
  • 可重复使用的
  • 全球智慧型胰岛素笔市场应用、表现及预测（2019-2024、2024-2029、2034）
  • 1型糖尿病
  • 2型糖尿病
  • 全球智慧型胰岛素笔市场终端用户、绩效及预测（2019-2024、2024-2029、2034）
  • 医院和诊所
  • 门诊手术中心
  • 居家照护
  • 全球智慧胰岛素笔市场：第一代笔细分、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 具有标准功能的基本智慧胰岛素笔
  • 轻鬆连接到行动应用程序，追踪和记录胰岛素剂量
  • 全球智慧胰岛素笔市场：第二代笔细分、类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 具有先进功能的高阶智慧胰岛素笔
  • 与医疗保健专业人员和看护者即时共用数据
  • 领先的综合糖尿病管理行动应用程式

第七章 区域和国家分析

  • 全球智慧胰岛素笔市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球智慧胰岛素笔市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 智慧胰岛素笔市场：竞争格局
  • 智慧胰岛素笔市场：公司简介
    • Companion Medical
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche AG
    • Emperra GmbH E-Health Technologies
    • Diamesco Co. Ltd.

第31章：其他领先和创新企业

  • Digital Medics Pvt Ltd.
  • Bigfoot Biomedical
  • Diabnext
  • Insulet Corporation
  • Jiangsu Delfu Medical Device Co. Ltd.
  • Sanofi India
  • Becton Dickinson
  • Biocon Ltd
  • Mehar healthcare
  • Johnson & Johnson
  • COVIDien Healthcare
  • Philips Healthcare India
  • Shandong WeiGao Group Medical Polymer Company Limited
  • Yuwell medical equipment & supply Co
  • Terumo

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年智慧胰岛素笔市场：提供新机会的国家
  • 2029年智慧胰岛素笔市场：细分市场带来新机会
  • 智慧胰岛素笔市场2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25953u

Smart insulin pens refer to insulin delivery devices designed to monitor and record dosage information, including volume, time, and type. Additionally, these devices may offer functionalities such as generating reports for sharing with healthcare professionals.

Two primary types of smart insulin pens exist first-generation pens and second-generation pens (equipped with Bluetooth or USB connectivity). Second-generation smart insulin pens incorporate Bluetooth or USB features to facilitate closer monitoring. These pens come in either prefilled or reusable forms and are utilized for the treatment of both type 1 diabetes and type 2 diabetes. Smart insulin pens find application across various end-users, including hospitals and clinics, ambulatory surgical centers, as well as home care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The smart insulin pens market research report is one of a series of new reports from The Business Research Company that provides smart insulin pens market statistics, including smart insulin pens industry global market size, regional shares, competitors with a smart insulin pens market share, detailed smart insulin pens market segments, market trends and opportunities, and any further data you may need to thrive in the smart insulin pens industry. This smart insulin pens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart insulin pens market size has grown strongly in recent years. It will grow from $0.11 billion in 2024 to $0.11 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increase in diabetes prevalence, strong economic growth in emerging markets, increased geriatric population, increased healthcare expenditure and public health insurance reforms.

The smart insulin pens market size is expected to see strong growth in the next few years. It will grow to $0.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to an increase in disease burden, government initiatives and technological enhancements. Major trends in the forecast period include collaborating with technology companies, smart insulin delivery devices, new types of insulin delivery, integrating internet of things and increasing mergers and acquisitions.

The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for dose-tracking microprocessors and precision injection mechanisms, key imports from Ireland and Israel, potentially delaying diabetes management solutions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Achieving an accurate dose of insulin is more feasible with an insulin pen compared to a vial or syringe. For scenarios such as children requiring insulin during school hours and visually impaired diabetic patients, the insulin pen allows for pre-setting an accurate dose over the dosage dial, ensuring precise delivery at the time of injection. Pediatric-friendly insulin pens such as Novo Nordisk's Echo Plus enable half-unit dosing, with a maximum of 30 units. Other options such as Lilly's HumaPen Luxura HD allow insulin delivery in half-unit increments, and Novo Nordisk's NovoPen Junior offers highly accurate insulin doses, finely adjusting even in half-unit increments. The precision in dose adjustments and delivery offered by smart insulin pens can prevent both over-dosing and under-dosing, contributing to the expected increase in demand for smart insulin pens and driving market growth.

The rising global diabetic population is expected to significantly boost the growth of the smart insulin pen market in the coming years. The diabetic population consists of individuals diagnosed with diabetes, a chronic condition characterized by elevated blood glucose levels. Smart insulin pens enhance diabetes management by providing precise insulin dosage tracking, reminders, and data integration, which improves treatment adherence and overall glycemic control for those with diabetes. For example, in July 2022, the International Diabetes Federation, a Belgium-based non-profit organization, reported that approximately 537 million adults worldwide were living with diabetes in 2022. This figure is projected to rise to 643 million by 2030 and further to 783 million by 2045. Thus, the increasing global diabetic population is driving the growth of the smart insulin pen market.

The next generation of smart insulin pens extends well beyond simple memory storage, they assist in calculating personalized doses, continuously track glucose levels, and connect to smartphone apps for data visualization. In April 2022, Eli Lilly and Company, a U.S.-based multinational pharmaceutical firm, announced the Tempo(R) Personalized Diabetes Management Platform. This comprehensive system is designed to improve diabetes self-management for adults with type 1 and type 2 diabetes. The Tempo Smart Button is a reusable device that attaches to the Tempo Pen, capturing and transferring insulin dosing data, while the TempoSmart(TM) App logs these doses and offers personalized education and medication reminders.

Major companies in the smart insulin pens market are strategically focusing on introducing user-friendly insulin pens, such as the NovoPen 6 and the NovoPen Echo Plus, to optimize revenue in the market. These self-injection pens automatically record insulin dosing information for each injection. For instance, in March 2022, Novo Nordisk A/S, a Denmark-based pharmaceutical company, launched the first smart insulin pens-NovoPen 6 and NovoPen Echo Plus. These pens record details such as the timing and quantity of insulin administered, uploading the data to an app via near-field communication (NFC). The pens facilitate the transfer of insulin dosing information to a patient's preferred diabetes app, allowing data sharing with healthcare providers. They are compatible with smartphones, tablets, personal computers, blood glucose monitors, or other NFC-supported devices.

In October 2023, Novo Nordisk A/S acquired Biocorp, a France-based medical device company specializing in the development and manufacturing of drug-delivery systems and medical devices, for $164.5 million. This acquisition is expected to enable Novo Nordisk to further invest in Biocorp's device development and expedite its ambitions within devices and delivery solutions.

Major companies operating in the smart insulin pens market include Companion Medical, Novo Nordisk A/S, F. Hoffmann-La Roche AG, Emperra GmbH E-Health Technologies, Diamesco Co. Ltd., Digital Medics Pvt Ltd., Bigfoot Biomedical, Diabnext, Insulet Corporation, Jiangsu Delfu Medical Device Co. Ltd., Sanofi India, Becton Dickinson, Biocon Ltd, Mehar healthcare, Johnson & Johnson, Covidien Healthcare, Philips Healthcare India, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Terumo, NIPRO, Olympus Medical Systems, Nihon Koden, Medtronic PLC, Ypsomed Holding AG, Berlin-Chemie AG, Patients Pending Ltd, Dexcom, Insujet, Eli Lilly., Abbott Laboratories, Tandem Diabetes Care, Inc.

North America was the largest region in the smart insulin pens market in 2024. Western Europe was the second largest region in the global smart insulin pens market share. The regions covered in the smart insulin pens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the smart insulin pens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The smart insulins pens market consists of sales of instruments such as first-generation pens and second-generation pens (Bluetooth enabled, USB connected). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Insulin Pens Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart insulin pens market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart insulin pens ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart insulin pens market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: First Generation Pens, Second Generation Pens
  • 2) By Usability: Prefilled, Reusable
  • 3) By Application: Type 1 Diabetes, Type 2 Diabetes
  • 4) By End User: Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings
  • Subsegments:
  • 1) By First Generation Pens: Basic Smart Insulin Pens With Standard Features; Simple Connectivity to Mobile Apps for Tracking and Logging Insulin Doses
  • 2) By Second Generation Pens: Advanced Smart Insulin Pens With Enhanced Features; Real-Time Data Sharing With Healthcare Providers and Caregivers; Sophisticated Mobile Applications for Comprehensive Diabetes Management
  • Companies Mentioned: Companion Medical; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Emperra GmbH E-Health Technologies; Diamesco Co. Ltd.; Digital Medics Pvt Ltd.; Bigfoot Biomedical; Diabnext; Insulet Corporation; Jiangsu Delfu Medical Device Co. Ltd.; Sanofi India; Becton Dickinson; Biocon Ltd; Mehar healthcare; Johnson & Johnson; Covidien Healthcare; Philips Healthcare India; Shandong WeiGao Group Medical Polymer Company Limited; Yuwell medical equipment & supply Co; Terumo; NIPRO; Olympus Medical Systems; Nihon Koden; Medtronic PLC; Ypsomed Holding AG; Berlin-Chemie AG; Patients Pending Ltd; Dexcom; Insujet; Eli Lilly.; Abbott Laboratories; Tandem Diabetes Care, Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Insulin Pens Market Characteristics

3. Smart Insulin Pens Market Trends And Strategies

4. Smart Insulin Pens Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Smart Insulin Pens Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Smart Insulin Pens PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Smart Insulin Pens Market Growth Rate Analysis
  • 5.4. Global Smart Insulin Pens Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Smart Insulin Pens Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Smart Insulin Pens Total Addressable Market (TAM)

6. Smart Insulin Pens Market Segmentation

  • 6.1. Global Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • First Generation Pens
  • Second Generation Pens
  • 6.2. Global Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prefilled
  • Reusable
  • 6.3. Global Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type 1 Diabetes
  • Type 2 Diabetes
  • 6.4. Global Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centres
  • Home Care Settings
  • 6.5. Global Smart Insulin Pens Market, Sub-Segmentation Of First Generation Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Basic Smart Insulin Pens With Standard Features
  • Simple Connectivity to Mobile Apps for Tracking and Logging Insulin Doses
  • 6.6. Global Smart Insulin Pens Market, Sub-Segmentation Of Second Generation Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Advanced Smart Insulin Pens With Enhanced Features
  • Real-Time Data Sharing With Healthcare Providers and Caregivers
  • Sophisticated Mobile Applications for Comprehensive Diabetes Management

7. Smart Insulin Pens Market Regional And Country Analysis

  • 7.1. Global Smart Insulin Pens Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Smart Insulin Pens Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Insulin Pens Market

  • 8.1. Asia-Pacific Smart Insulin Pens Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Insulin Pens Market

  • 9.1. China Smart Insulin Pens Market Overview
  • 9.2. China Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Insulin Pens Market

  • 10.1. India Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Insulin Pens Market

  • 11.1. Japan Smart Insulin Pens Market Overview
  • 11.2. Japan Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Insulin Pens Market

  • 12.1. Australia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Insulin Pens Market

  • 13.1. Indonesia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Insulin Pens Market

  • 14.1. South Korea Smart Insulin Pens Market Overview
  • 14.2. South Korea Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Insulin Pens Market

  • 15.1. Western Europe Smart Insulin Pens Market Overview
  • 15.2. Western Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Insulin Pens Market

  • 16.1. UK Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Insulin Pens Market

  • 17.1. Germany Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Insulin Pens Market

  • 18.1. France Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Insulin Pens Market

  • 19.1. Italy Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Insulin Pens Market

  • 20.1. Spain Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Insulin Pens Market

  • 21.1. Eastern Europe Smart Insulin Pens Market Overview
  • 21.2. Eastern Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Insulin Pens Market

  • 22.1. Russia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Insulin Pens Market

  • 23.1. North America Smart Insulin Pens Market Overview
  • 23.2. North America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Insulin Pens Market

  • 24.1. USA Smart Insulin Pens Market Overview
  • 24.2. USA Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Insulin Pens Market

  • 25.1. Canada Smart Insulin Pens Market Overview
  • 25.2. Canada Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Insulin Pens Market

  • 26.1. South America Smart Insulin Pens Market Overview
  • 26.2. South America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Insulin Pens Market

  • 27.1. Brazil Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Insulin Pens Market

  • 28.1. Middle East Smart Insulin Pens Market Overview
  • 28.2. Middle East Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Insulin Pens Market

  • 29.1. Africa Smart Insulin Pens Market Overview
  • 29.2. Africa Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Insulin Pens Market Competitive Landscape And Company Profiles

  • 30.1. Smart Insulin Pens Market Competitive Landscape
  • 30.2. Smart Insulin Pens Market Company Profiles
    • 30.2.1. Companion Medical Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Emperra GmbH E-Health Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Diamesco Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Smart Insulin Pens Market Other Major And Innovative Companies

  • 31.1. Digital Medics Pvt Ltd.
  • 31.2. Bigfoot Biomedical
  • 31.3. Diabnext
  • 31.4. Insulet Corporation
  • 31.5. Jiangsu Delfu Medical Device Co. Ltd.
  • 31.6. Sanofi India
  • 31.7. Becton Dickinson
  • 31.8. Biocon Ltd
  • 31.9. Mehar healthcare
  • 31.10. Johnson & Johnson
  • 31.11. Covidien Healthcare
  • 31.12. Philips Healthcare India
  • 31.13. Shandong WeiGao Group Medical Polymer Company Limited
  • 31.14. Yuwell medical equipment & supply Co
  • 31.15. Terumo

32. Global Smart Insulin Pens Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Insulin Pens Market

34. Recent Developments In The Smart Insulin Pens Market

35. Smart Insulin Pens Market High Potential Countries, Segments and Strategies

  • 35.1 Smart Insulin Pens Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Smart Insulin Pens Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Smart Insulin Pens Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer